Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab vs Cisplatin with Radiotherapy in Nasopharyngeal Carcinoma
NCT01614938Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Aug 2010
- Primary completion
- Aug 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in nasopharyngeal carcinoma (NPC), sponsored by Fudan University. Status: unknown.
02
Drugs
cetuximab
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01614938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614938.